HGC Investment Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

HGC Investment Management’s Portfolio BIOSU Stock Details BIOSU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-500,000	Closed	-$5.24M	–	203
2023 Q1	$5.24M	Hold	500,000	–	–	1.07%	29
2022 Q4	$5.12M	Hold	500,000	–	–	0.53%	62
2022 Q3	$5.02M	Sell	500,000 -500,000	-50%	-$5.01M	0.34%	86
2022 Q2	$10M	Buy	1,000,000 +500,000	+100%	+$5M	0.31%	93
2022 Q1	$4.99M	Hold	500,000	–	–	0.3%	104
2021 Q4	$5M	Buy	+500,000	New	+$5.01M	0.31%	101

Other funds holding BIOSU

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

HGC Investment Management's BIOSU Position: Q2 2023 in Review

HGC Investment Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2023, closing a stake of 500,000 shares — an estimated $5.24M sold.

HGC Investment Management first reported a position in BIOSU in Q4 2021 and held it in 6 quarters. The position peaked at $10M in Q2 2022. 2 funds tracked by Wall St. Rank hold BIOSU as of Q2 2023.

HGC Investment Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
HGC Investment Management sold 500,000 BioPlus Acquisition Corp. Unit shares in Q2 2023, an estimated $5.24M.
HGC Investment Management first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 6 quarters.
HGC Investment Management's BioPlus Acquisition Corp. Unit position peaked at $10M in Q2 2022.
2 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2023.

Based on HGC Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.